Search

everythinglearnresearchcommunity

for

Search:↓

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Baricitinib is effective for severe alopecia areata but has some side effects.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Specific miRNA profiles can help diagnose and treat alopecia areata.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

A 72-year-old man had severe fatigue, weight loss, and frequent loose stools.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Anti-androgens are safe and effective for treating moderate to severe adult female acne.